So, the use of AChE inhibitors (AChEIs) for presentation of the cholinergic breakdown of ACh is a prospective and strong strategy to treat AD (Cetin Cakmak & Gülçin, 2019). This evidence concerns the gene ACHE and Alzheimer disease.